No profile data available.
Panbela Therapeutics, Inc. (PBLA) is a healthcare company in the additional cancer treatment drugs industry, based in Waconia, United States, with about 7 full-time employees.
It reported revenue of $0 for fiscal year 2023, and net income of -$25.26 million. In Q3 2024 (the quarter ended September 30, 2024) revenue was $0. Its market capitalization was $4,854 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 8, 2026.
, a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.
Panbela Therapeutics reported $0 in revenue for fiscal year 2023. In Q3 2024 revenue was $0.
$4,854 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Nascent Biotech, Inc. (NBIO), Carisma Therapeutics, Inc. (CARM), Affimed N.v. (AFMDQ), eFFECTOR Therapeutics, Inc. (EFTR).